Richard T. Hoppe

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

<i>PD-L1</i> and <i>PD-L2</i> Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha G.M. Roemer, Ranjana H. Advani, Azra H. Ligon et al. · Journal of Clinical Oncology · 2016 · 783 citations · Full text

Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome

Youn H. Kim, Howard L. Liu, Serena Mraz‐Gernhard et al. · Archives of Dermatology · 2003 · 645 citations

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Lena Specht, Joachim Yahalom, Tim Illidge et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 567 citations

Lymphoid Neoplasia, Radiation Medicine, Hodgkin Lymphoma +7